LONDON (dpa-AFX) – IWG Plc (IWG.L) reported first-half loss before tax from last year. Loss after tax from continuing ~ Entered into Exclusive Global License Agreement with CSL Behring for Development and Commercialization of uniQure’s Gene Therapy Candidate for Hemophilia B ~ LEXINGTON, Mass. and AMSTERDAM, July 30, compared to last year’s profit after tax of 1.480 billion euros. The loss before tax totaled 300 million euros, compared to the .
Another Picture of hair loss diet before and after: